Enhancing CMC Efficiency with Augmented Intelligence for Biotechs
Impossibile aggiungere al carrello
Rimozione dalla Lista desideri non riuscita.
Non è stato possibile aggiungere il titolo alla Libreria
Non è stato possibile seguire il Podcast
Esecuzione del comando Non seguire più non riuscita
Enhancing CMC Efficiency with Augmented Intelligence for Biotechs
-
Letto da:
-
Di:
The Podcast focuses on how technology, specifically augmented intelligence (AI), can improve the efficiency and compliance of drug development. The article emphasizes the importance of technology in streamlining back-office operations and supporting the regulatory aspects of Chemistry, Manufacturing, and Controls (CMC) for pharmaceutical companies. The text highlights how AI-powered solutions can automate processes, enhance collaboration, and provide data-driven insights to help companies navigate complex regulatory submissions. The article showcases Enkrisi, a company utilizing AI-powered solutions to revolutionize regulatory CMC, and presents their platform, EnkrisiGPT, as a cutting-edge solution for navigating the complexities of drug development.
Support the show